B3. Operating expenses
Operating expenses by function and type of cost
SEKm |
2019 |
2018 |
2017 |
IS Cost of goods sold |
–90,876 |
–85,058 |
–76,899 |
IS Sales, general and administration |
–22,319 |
–20,570 |
–19,130 |
IS Share of profits of associated companies and joint ventures |
60 |
63 |
169 |
IS Amortization of acquisition-related intangible assets |
–778 |
–732 |
–560 |
IS TB3:1 Items affecting comparability |
–713 |
–1,444 |
–940 |
Total |
–114,626 |
–107,741 |
–97,360 |
Refer also to the Description of costs section.
SEKm |
Note |
2019 |
2018 |
2017 |
||||
|
||||||||
TB3:2 Other income |
|
1,028 |
897 |
1,045 |
||||
Change in inventory of finished products and products in progress1) |
|
–962 |
196 |
172 |
||||
Raw materials and consumables1) |
|
–43,800 |
–43,771 |
–38,191 |
||||
Personnel costs1) |
–23,888 |
–22,021 |
–20,142 |
|||||
TB3:3 Other operating expenses1) |
|
–39,399 |
–36,412 |
–34,444 |
||||
Amortization of intangible assets1) |
–1,111 |
–1,049 |
–853 |
|||||
Depreciation of property, plant and equipment1) |
–6,366 |
–5,126 |
–4,871 |
|||||
Impairment of intangible assets1) |
–19 |
–105 |
–132 |
|||||
Impairment of property, plant and equipment1) |
–152 |
–428 |
–254 |
|||||
Reversal of impairment of property, plant and equipment1) |
119 |
– |
– |
|||||
Share in profits of associated companies and joint ventures1) |
|
84 |
–215 |
169 |
||||
Revaluation of previously owned shares in associated companies1) |
– |
225 |
72 |
|||||
Gain/loss on divestment and liquidation1) 2) |
|
–160 |
68 |
69 |
||||
Total |
|
–114,626 |
–107,741 |
–97,360 |
TB3:1 Items affecting comparability
SEKm |
2019 |
2018 |
2017 |
Impairment of inventory of finished products and products in progress, net |
–70 |
–61 |
–4 |
Impairment of trade receivables |
–10 |
– |
– |
Personnel costs |
–445 |
–700 |
–69 |
Other operating expenses |
–79 |
–183 |
–620 |
Amortization of intangible assets |
– |
– |
–2 |
Impairment of intangible assets, net |
–16 |
–105 |
–132 |
Impairment of property, plant and equipment, net |
43 |
–410 |
–254 |
Share in profits of associated companies from impairment and divestments |
24 |
–278 |
– |
Revaluation of previously owned shares in associated companies |
– |
225 |
72 |
Gain/loss on divestment and liquidation |
–160 |
68 |
69 |
Total |
–713 |
–1,444 |
–940 |
SEKm |
2019 |
Restructuring costs relating to the Group-wide cost-savings program |
–409 |
Costs for other restructuring programs |
–181 |
Transfer to profit or loss of realized translation differences relating to divested and liquidated companies |
–178 |
Other |
55 |
Total |
–713 |
SEKm |
2018 |
Costs for restructuring measures at production facilities of Professional Hygiene and Consumer Tissue |
–1,222 |
Impairment in the associated company Asaleo Care Ltd. |
–278 |
Restructuring costs relating to the Group-wide cost-savings program |
–131 |
Dissolution of reserve for foreign tax |
288 |
Increase in participations in joint venture in Latin America |
165 |
Other |
–266 |
Total |
–1,444 |
SEKm |
2017 |
Costs of split of SCA Group into two listed companies |
–550 |
Integration and transaction costs related to the acquisition of BSN medical and inventory valuation arising from acquisition balance |
–435 |
Closure of tissue production plant in the USA |
–255 |
Restructuring costs for the closure of the tissue machine in the UK |
–75 |
Dissolution of provisions for competition case in Poland |
265 |
Other |
110 |
Total |
–940 |
SEKm |
2019 |
2018 |
2017 |
Sales not included in core operations |
1,028 |
897 |
1,045 |
Total |
1,028 |
897 |
1,045 |
Other income includes rental income, which is recognized in the period covered by the rental contract, royalties and similar items, which are recognized in accordance with the implied financial effect of the contract.
SEKm |
2019 |
2018 |
2017 |
||||
|
|||||||
Transport expenses |
–9,360 |
–8,290 |
–7,425 |
||||
Energy costs1) |
–5,125 |
–4,775 |
–4,498 |
||||
Purchased finished goods for resale |
–6,811 |
–5,144 |
–5,053 |
||||
Marketing costs |
–6,604 |
–6,031 |
–5,777 |
||||
Repairs and maintenance |
–2,927 |
–2,546 |
–2,436 |
||||
IT, telephony and lease of premises2) |
–903 |
–1,633 |
–1,380 |
||||
Other operating expenses, production |
–4,092 |
–3,919 |
–3,671 |
||||
Other operating expenses, distribution, sales and administration |
–3,481 |
–3,674 |
–3,644 |
||||
Other |
–96 |
–400 |
–560 |
||||
Total |
–39,399 |
–36,412 |
–34,444 |
Other disclosures
Exchange rate effects had a negative impact of SEK –70m (–186; –10) on operating profit. Government grants received reduced operating expenses by SEK 47m (55; 65). Costs for research and development amounted to SEK –1,485m (–1,320; –1,239) during the period.